EICHOR
● Completed
A Study to the Assess the Change in Condition and Adverse Events of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines
Condition: Glabellar Lines · Sponsor: Allergan
About this study
This is a Phase 2, dose ranging study to evaluate the safety of OnabotulinumtoxinA X and to compare the efficacy of OnabotulinumtoxinA X and placebo for the treatment of Glabellar Lines in adult participants with moderate to severe GL.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (18)
| Advanced Research Associates - Glendale /ID# 230418 | Glendale, Arizona, United States | — |
| Westside Aesthetics /ID# 230305 | Los Angeles, California, United States | — |
| The Eye Research Foundation /ID# 232544 | Newport Beach, California, United States | — |
| The Research Center at The Maas Clinic /ID# 230685 | San Francisco, California, United States | — |
| Center for Dermatology and Dermatologic Surgery /ID# 230684 | Washington D.C., District of Columbia, United States | — |
| Steven Fagien MD Aesthetic Eyelid Plastic Surgery /ID# 232542 | Boca Raton, Florida, United States | — |
| Baumann Cosmetic and Research Institute /ID# 232545 | Miami, Florida, United States | — |
| Research Institute of the Southeast, LLC /ID# 230436 | West Palm Beach, Florida, United States | — |
| Coleman Center For Cosmetic Dermatologic Surgery /ID# 230693 | Metairie, Louisiana, United States | — |
| Etre Cosmetic Dermatology and Laser Center /ID# 230437 | New Orleans, Louisiana, United States | — |
| SLUCare Cosmetic Dermatology /ID# 230333 | St Louis, Missouri, United States | — |
| Laser & Skin Surgery Center of New York /ID# 230683 | New York, New York, United States | — |
+ 6 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05100199